Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-methyl-4-(2-hydroxyisopropyl)cyclohex-1,2-en-6-ol
2. 1-methyl-alpha-hydroxyisopropylcyclohexenol-6
3. Sobrepin
4. Sobrerol, (+-)-isomer
1. 498-71-5
2. 5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-enol
3. Soberol
4. Sobrepin
5. 5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol
6. 5-hydroxy-alpha,alpha,4-trimethylcyclohex-3-ene-1-methanol
7. (+/-)-1-hydroxyisodihydrocarveol
8. Pinol Hydrate
9. Pinolhydrat
10. 6,8-carvomenthenediol; Nsc 408849; Pinol Hydrate; Sobrepin
11. Cyclidrol
12. D,l-trans-sobrerol; Dl-sobrerol; Trans-6-hydroxy-alpha-terpineol
13. 1,2-cyclohexanediol, 1-methyl-4-(1-methylethenyl)-, (1alpha,2alpha,4beta)- (9ci); 1,2-cyclohexanediol, 1-methyl-4-(1-methylethenyl)-, (1alpha,2alpha,4beta)-(+/-)-
14. Ccris 7135
15. 6,8-carvomenthendiol
16. 42370-41-2
17. Einecs 207-868-1
18. Ai3-23138
19. Mucoflux (tn)
20. Sobrepin (tn)
21. Nciopen2_000885
22. Oprea1_276529
23. Schembl1649171
24. Chembl2228862
25. Dtxsid90871701
26. Chebi:134802
27. (1s)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol
28. Nsc43652
29. Nsc74541
30. 3-cyclohexene-1-methanol, 5-hydroxy-.alpha.,.alpha.,4-trimethyl-
31. 3-cyclohexene-1-methanol, 5-hydroxy-alpha,alpha,4-trimethyl-, (+/-)
32. Nsc-43652
33. Nsc-74541
34. Nsc408849
35. Akos006230491
36. P-menth-6-ene-2,8-diol, ( )-
37. Nsc-408849
38. Db-050902
39. Ft-0630625
40. D08520
41. 6,8-carvomenthenedioll-p-methene-6,8-diolpinol Hydrate
42. 5-hydroxy-.alpha.,.alpha.,4-trimethyl-3-cyclohexene-1-methanol
43. 3-cyclohexene-1-methanol, 5-hydroxy-.alpha.,.alpha.,4-trimethyl-, Trans-( )-
Molecular Weight | 170.25 g/mol |
---|---|
Molecular Formula | C10H18O2 |
XLogP3 | 0.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 170.130679813 g/mol |
Monoisotopic Mass | 170.130679813 g/mol |
Topological Polar Surface Area | 40.5 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 194 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Expectorants
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)
R - Respiratory system
R05 - Cough and cold preparations
R05C - Expectorants, excl. combinations with cough suppressants
R05CB - Mucolytics
R05CB07 - Sobrerol
Global Sales Information
Market Place
ABOUT THIS PAGE
22
PharmaCompass offers a list of Soberol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Soberol manufacturer or Soberol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Soberol manufacturer or Soberol supplier.
PharmaCompass also assists you with knowing the Soberol API Price utilized in the formulation of products. Soberol API Price is not always fixed or binding as the Soberol Price is obtained through a variety of data sources. The Soberol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mucoflux (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mucoflux (TN), including repackagers and relabelers. The FDA regulates Mucoflux (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mucoflux (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mucoflux (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mucoflux (TN) supplier is an individual or a company that provides Mucoflux (TN) active pharmaceutical ingredient (API) or Mucoflux (TN) finished formulations upon request. The Mucoflux (TN) suppliers may include Mucoflux (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Mucoflux (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mucoflux (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Mucoflux (TN) active pharmaceutical ingredient (API) in detail. Different forms of Mucoflux (TN) DMFs exist exist since differing nations have different regulations, such as Mucoflux (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mucoflux (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Mucoflux (TN) USDMF includes data on Mucoflux (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mucoflux (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mucoflux (TN) suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mucoflux (TN) Drug Master File in Korea (Mucoflux (TN) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mucoflux (TN). The MFDS reviews the Mucoflux (TN) KDMF as part of the drug registration process and uses the information provided in the Mucoflux (TN) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mucoflux (TN) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mucoflux (TN) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mucoflux (TN) suppliers with KDMF on PharmaCompass.
Mucoflux (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mucoflux (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mucoflux (TN) GMP manufacturer or Mucoflux (TN) GMP API supplier for your needs.
A Mucoflux (TN) CoA (Certificate of Analysis) is a formal document that attests to Mucoflux (TN)'s compliance with Mucoflux (TN) specifications and serves as a tool for batch-level quality control.
Mucoflux (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Mucoflux (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mucoflux (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Mucoflux (TN) EP), Mucoflux (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mucoflux (TN) USP).